Raymond James Financial Inc Tg Therapeutics, Inc. Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 481,989 shares of TGTX stock, worth $16.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
481,989Holding current value
$16.1 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
354Shares Held
90.2MCall Options Held
2.35MPut Options Held
1.7M-
Vanguard Group Inc Valley Forge, PA15.4MShares$515 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$382 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$305 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$120 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$107 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $4.87B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...